n-(n-benzylpiperidin-4-yl)-4-iodobenzamide and Glioblastoma

n-(n-benzylpiperidin-4-yl)-4-iodobenzamide has been researched along with Glioblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bontempi, G; De Neve, N; Debeir, O; Decaestecker, C; Gailly, P; Haibe-Kains, B; Kiss, R; Kondo, Y; Lefranc, F; Mathieu, V; Mégalizzi, V; Mijatovic, T; Van Damme, M	1

Other Studies

1 other study(ies) available for n-(n-benzylpiperidin-4-yl)-4-iodobenzamide and Glioblastoma

Article	Year
4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:5 Topics: Actins; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Calcium; Cell Line, Tumor; Cell Movement; Endoplasmic Reticulum; Female; Glioblastoma; Guanine Nucleotide Dissociation Inhibitors; Humans; Mice; Neoplasm Transplantation; Piperidines; Receptors, sigma; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Transplantation, Heterologous	2007

Article

Year

4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.

Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:5

Topics: Actins; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Calcium; Cell Line, Tumor; Cell Movement; Endoplasmic Reticulum; Female; Glioblastoma; Guanine Nucleotide Dissociation Inhibitors; Humans; Mice; Neoplasm Transplantation; Piperidines; Receptors, sigma; rho-Specific Guanine Nucleotide Dissociation Inhibitors; Transplantation, Heterologous

2007